Clinical safety and effectiveness of biphasic insulin aspart 30 in type 2 diabetes patients switched from biphasic human insulin 30: Results from the Indonesian cohort of the A1chieve study

• Main Authors: Pradana Soewondo, Dharma Lindarto, Sony Wibisono, Olly Renaldi, Tjokorda Gde Dalem-Pemayua
• Format: Article PeerReviewed
• Language: English; English; English
• Published: Elsevier BV 2013
• Subjects: R Medicine (General); RC Internal medicine
• Online Access: http://repository.unair.ac.id/108343/1/C-08.pdf; http://repository.unair.ac.id/108343/2/C-08%20kadep.pdf; http://repository.unair.ac.id/108343/3/C-08%20turnitin.pdf; http://repository.unair.ac.id/108343/; https://www.diabetesresearchclinicalpractice.com/article/S0168-8227(13)70009-3/fulltext; https://doi.org/10.1016/S0168-8227(13)70009-3
• Institution: Universitas Airlangga

Aim To evaluate the safety and effectiveness of biphasic insulin aspart 30 (BIAsp 30) in Indonesian type 2 diabetes patients switched from biphasic human insulin 30 (BHI 30) as a sub-analysis of the A1chieve study. Methods Clinical safety and effectiveness over 24 weeks was evaluated in Indonesian p...